T
GLP-1 / GIP Dual Agonist
247 Reviews

Compounded Tirzepatide

Tirzepatide is the active compound in Mounjaro and Zepbound. By activating both GLP-1 and GIP receptors simultaneously, it produces meaningfully greater weight loss than single-receptor agonists — with a growing body of clinical evidence to support it.

Starting at $199 / month


NEW! Now Available: Microdose Tirzepatide

Low-dose option available for eligible patients seeking a gentler start or those looking for ongoing support in maintaining their results.

Dosage:

Plan:

Get Started

+ Free provider consultation included

Compounded semaglutide being drawn into a syringe from a vial

The goal was never just a lower number on the scale.

It's waking up energized. Feeling comfortable in your favorite clothes. Saying yes to beach days, family photos, and new adventures without hesitation. Semaglutide can be a powerful tool for reducing hunger and supporting weight loss, but the real transformation is often how people feel along the way.

Start your journey today.

Women jumping from a sailboat into the ocean
Aerial view of a boat cutting through deep blue ocean water
SailRx compounded medication vial on a spilled pink liquid background

I plateaued on semaglutide at about 15 pounds. Switched to tirzepatide six weeks ago and I'm already down another 9. The dual mechanism is real.

Patricia H.

More aggressive than I expected in the best way. The appetite suppression kicked in fast and stayed consistent across my whole dosing week.

Derek W.

My provider was upfront about the titration timeline. 16 weeks sounds long but the results compound. I'm down 31 pounds at week 20.

Lisa F.

Read More Reviews

Other treatments

View all